Along with the company's other compounds, the mechanism of action and molecular structure of R327 differs very substantially from the traditional antibiotic. As a consequence, those same characteristics have been shown to allow it to exert anti-viral activity as well as anti-bacterial.
Because of these unusual and more broadly active properties, and also because of the wide potential range of uses, they are being referred to, quite appropriately, as ‘anti-infective’ rather than as ‘anti-biotic’.
poorinvestor
- Forums
- ASX - By Stock
- RCE
- [INTERVIEW] CEO buys another $300,000 stake in Recce Pharmaceuticals (ASX:RCE)
RCE
recce pharmaceuticals ltd
Add to My Watchlist
0.65%
!
38.8¢

[INTERVIEW] CEO buys another $300,000 stake in Recce Pharmaceuticals (ASX:RCE), page-22
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
38.8¢ |
Change
0.003(0.65%) |
Mkt cap ! $112.0M |
Open | High | Low | Value | Volume |
38.5¢ | 39.0¢ | 38.0¢ | $4.167K | 10.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 24610 | 38.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 49817 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 24610 | 0.380 |
1 | 3248 | 0.375 |
2 | 33181 | 0.365 |
2 | 71806 | 0.360 |
2 | 85000 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 49817 | 1 |
0.400 | 23104 | 2 |
0.410 | 25471 | 1 |
0.435 | 5115 | 1 |
0.440 | 8669 | 2 |
Last trade - 15.44pm 31/07/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |